Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

New Colon Cancer Screening Guidelines Add Blood And At-Home Tests By Dennis Thompson HealthDay ReporterTHURSDAY, May 28, 2026 (HealthDay News) — Blood tests taken in a doctor’s office now can be used ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Ontario has lowered the eligibility age for colon cancer screening from 50 to 45, a move that cancer survivor Ashley Wiley ...